Libre Rio连续葡萄糖监测系统
K号: K233861 · 2024-06-07
广告
决定日期2024-06-07
产品代码SBH
咨询委员会CH
请注意，您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。
决定实质等同
器械摘要
Libre Rio Continuous Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Diabetes Care. It received FDA 510(k) clearance on 2024-06-07 under 510(k) number K233861. The device is classified under product code SBH. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the Libre Rio Continuous Glucose Monitoring System?
Libre Rio Continuous Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2024-06-07. The listed applicant is Abbott Diabetes Care. The 510(k) number is K233861.
When did Libre Rio Continuous Glucose Monitoring System receive FDA 510(k) clearance?
Libre Rio Continuous Glucose Monitoring System received FDA 510(k) clearance on 2024-06-07, under 510(k) number K233861.
Who is the listed applicant for Libre Rio Continuous Glucose Monitoring System?
The FDA 510(k) record lists Abbott Diabetes Care as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Libre Rio Continuous Glucose Monitoring System?
The FDA product code for Libre Rio Continuous Glucose Monitoring System is SBH.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：SBH）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告